Kerrie Sandgren co-leads the Vaccines and Adjuvants research group at The Westmead Institute for Medical Research (WIMR).
Kerrie received her PhD from the University New South Wales in 2008 and went on to complete a post-doc at the Karolinska Institute, Sweden. Part of her post-doc was also spent at the Vaccine Research Centre, NIH, USA. Her research focused on the role of dendritic cells in viral immunity and vaccination, and she developed an interest in the potential of vaccine adjuvants. She is now a senior research scientist, co-leading the Vaccines and Adjuvants research groups at WIMR.
The group utilises an in situ human lymph node model that she developed to study how vaccines and adjuvants work at their actual site of action in the human body. She also uses this model to study the influence of ageing on vaccine responses.
The group also focuses on COVID-19 immunology following infection and vaccination and is involved in several clinical trials. Kerrie collaborates with GlaxoSmithKline and Moderna and she is the recipient of a Moderna Global Fellowship.
Vaccination immunology, adjuvant, vaccines, lymph node, innate immunity
Infection and Immunological Conditions